未登录

H

Hanne Norsgaard

Leo Pharma

H指数:15

被引数:870

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

IL-4 and IL-13 both contribute to the homeostasis of human conjunctival goblet cells in vitro

IF12

2022-05-0620

OA

Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment

用于局部治疗的新型非甾体类糖皮质激素受体激动剂的表征

SCIENTIFIC REPORTS

IF3.9

2022-01-279

OAAI

Signalling of multiple interleukin (IL)-17 family cytokines via IL-17 receptor A drive psoriasis-related inflammatory pathways

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2021-05-3135

OAAI

Calcipotriol/Betamethasone Dipropionate Foam Inhibits Th17 Cytokine Secretion and Improves Epidermal Barrier Markers in a Human Th17 Skin Inflammation Model

DERMATOLOGY AND THERAPY

IF4.2

2021-01-174

OAAI

Skin Barrier and Inflammation Genes Associated with Atopic Dermatitis are Regulated by Interleukin-13 and Modulated by Tralokinumab In vitro

ACTA DERMATO-VENEREOLOGICA

IF3.7

2021-01-0115

OAAI

Development and characterization of a human Th17-driven ex vivo skin inflammation model

EXPERIMENTAL DERMATOLOGY

IF3.1

2020-08-2514

OAAI

Short-term transcriptional response to IL-17 receptor-A antagonism in the treatment of psoriasis

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2020-03-0144

OAAI

Ex vivo culture of lesional psoriasis skin for pharmacological testing

JOURNAL OF DERMATOLOGICAL SCIENCE

IF4

2020-02-018

OAAI

Evaluation of pharmacological responses in InflammaSkin® a fully human full-thickness ex vivo skin model reproducing key features of psoriatic lesions

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2018-05-010

OAAI

Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation

NATURE COMMUNICATIONS

IF15.7

2018-04-1296

OAAI

Effects of glucocorticoids on stratum corneum lipids and function in human skin-A detailed lipidomic analysis

糖皮质激素对人皮肤角质层脂质和功能的影响-详细的脂质组学分析

JOURNAL OF DERMATOLOGICAL SCIENCE

IF4

2017-12-0125

PREAI

Evaluation of pharmacological responses in a fully human ex vivo skin model following in situ T cell activation with Th17 / Th1 psoriasis-like phenotype

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2017-10-011

OAAI

Preclinical evaluation of a novel non-steroidal glucocorticoid receptor agonist with low systemic exposure and reduced potential for skin atrophy

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2017-10-010

OAAI

Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis (vol 81, pg 153, 2016)

JOURNAL OF DERMATOLOGICAL SCIENCE

IF4

2017-02-011

PREAI

Supersaturation of Calcipotriene and Betamethasone Dipropionate in a Novel Aerosol Foam Formulation for Topical Treatment of Psoriasis Provides Enhanced Bioavailability of the Active Ingredients

DERMATOLOGY AND THERAPY

IF4.2

2016-06-2964

OAAI

Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis

JOURNAL OF DERMATOLOGICAL SCIENCE

IF4

2016-03-0165

OAAI

Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis

EXPERIMENTAL DERMATOLOGY

IF3.1

2016-02-2661

PREAI

Translating clinical activity and gene expression signatures of etanercept and ciclosporin to the psoriasis xenograft SCID mouse model

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2012-01-1913

PREAI

Psoriasis drug discovery: methods for evaluation of potential drug candidates

EXPERT OPINION ON DRUG DISCOVERY

IF4.9

2011-11-0812

PRE

IL-23-Mediated Epidermal Hyperplasia Is Dependent on IL-6

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2011-05-0162

OAAI